Christiana S. Kappler, Ph.D.

Affiliations: 
2006 Medical University of South Carolina, Charleston, SC, United States 
Area:
Cell Biology, Molecular Biology
Google:
"Christiana Kappler"

Parents

Sign in to add mentor
Donald R. Menick grad student 2006 MUSC
 (Pathways mediating sodium -calcium exchanger expression.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Giordano A, Liu Y, Armeson K, et al. (2019) Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. Plos One. 14: e0224420
Giordano A, Liu Y, Armeson K, et al. (2019) Abstract P5-03-03: Polo-like Kinase 1 (PLK1) inhibition synergizes with docetaxel in basal breast cancer cells Cancer Research. 79
Giordano A, Liu Y, Kappler C, et al. (2019) Polo-like kinase 1 inhibitor onvansertib synergizes with paclitaxel in breast cancer carrying p53 mutation Annals of Oncology. 30
Smith EL, Kappler CS, Ethier SP. (2017) Abstract 1339: Role of PTEN loss in basal-like 2 triple negative breast cancer Cancer Research. 77: 1339-1339
Irish JC, Mills JN, Turner-Ivey B, et al. (2016) Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer. Molecular Oncology
Kappler CS, Smith EL, Ethier S. (2016) Abstract 4596: Regulation of epidermal growth factor receptor signaling in triple-negative breast cancer Cancer Research. 76: 4596-4596
Kappler CS, Guest ST, Irish JC, et al. (2015) Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Molecular Oncology. 9: 527-43
Kappler CS, Guest ST, Smith EL, et al. (2015) Abstract 1949: Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer Cancer Research. 75: 1949-1949
Turner-Ivey B, Guest ST, Irish JC, et al. (2014) KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia (New York, N.Y.). 16: 644-55
Kappler C, Wilson R, Varughese B, et al. (2014) Abstract 3297: PTEN loss enhances amphiregulin-specific signaling and gene expression in triple-negative breast cancer Cancer Research. 74: 3297-3297
See more...